Healthcare Realty Trust Incorporated (HR) Cash Flow Statement

The dividend-to-AFFO ratio exceeded 1.0x in 2025Q3 and 2024Q4 and was well above that level in 2024Q2, which suggests the distribution has at times been funded from sources other than recurring cash generation. The 2026Q2 AFFO of $26.3M against roughly $82M in dividends points to a sharp shortfall that investors should monitor closely. Coverage should be judged on a trailing basis given how erratic single-quarter AFFO has been.

The gap between operating cash flow and FFO fluctuates widely, which appears to reflect working capital timing and rent collection cadence rather than a stable earnings base. Free cash flow margins swung from roughly 32% in 2024Q2 to negative territory in 2026Q1, suggesting capital intensity and cash timing are driving much of the variation. Investors should treat single-quarter conversion ratios with caution.

Heavy capex relative to operating cash flow may reflect tenant improvements, leasing costs, and acquisition or development activity, although the split is not disclosed in the supplied data. This appears to leave limited residual cash for distributions without external funding. Whether this spending is maintenance-driven or growth-oriented warrants further investigation.

When distributions exceed recurring cash earnings, the shortfall must be met through debt, equity issuance, or asset sales, and the supplied data does not show which. The rising debt-related scrutiny in prior analysis reinforces this concern. Investors should monitor financing activity and any changes to the distribution level.

Depreciation and amortization on acquired real estate, including the HTA integration, appears to depress GAAP net income substantially while leaving cash-based earnings intact. This distortion makes net income an unreliable guide to distributable capacity for a REIT of this profile. FFO and AFFO remain the more relevant lenses, though their recent volatility limits confidence in any single period.